Tuesday, October 30, 2018

Intabio Finds $9.5M

Newark-based Intabio, a developer of biotherapeutics technology, announced on Tuesday that it had raised $9.5M in a Series A funding round. The funding was led by Northpond Ventures, and also included Genoa Ventures and Vertical Venture Partners. Intabio said the new funding comes on top of an earlier $3.2M seed funding it raised in 2017. Intabio says it is developing a comprehensive analysis of antibody and protein biopharmaceutical products to help biopharma companies meet the accelerated timelines required for breakthrough therapy applications.